IGF-1 LR3 · Research brief

IGF-1 LR3 Price — What Research-Grade Vials Cost

Real Peptides Research TeamEditorial

Updated September 16, 20269 min read

59 WORDS

Short answer

The cheapest vial on the page is almost never the cheapest protein. IGF-1 LR3 (Long R3 insulin-like growth factor 1) is an 83-amino-acid recombinant protein carrying three internal disulfide bonds, and a vial label reports gross fill weight, not net peptide content. Two listings showing an identical IGF-1 LR3 price can contain meaningfully different amounts of correctly folded material.

Key takeaways

IGF-1 LR3 price typically runs from roughly $40 to over $100 per 1mg research vial, with per-milligram cost falling at larger fill sizes.
IGF-1 LR3 is an 83-amino-acid recombinant analog of human IGF-1, roughly 9,100 Da, made by expression and refolding rather than solid-phase synthesis.
Refolding is the yield-limiting step, because three disulfide bridges must pair correctly and misfolded isomers share the identical molecular mass as correctly folded protein.
HPLC purity and mass spectrometry cannot separate disulfide isomers, which is why bioactivity data adds information a purity percentage alone cannot.
Net peptide content, not gross fill weight, is the correct denominator when calculating true cost per milligram.
Lyophilized material is stored frozen and reconstituted solution refrigerated at 2 to 8°C, and a broken cold chain destroys value no listing page reflects.
Research-use-only classification means the material is not a drug product and is not intended for human or animal administration.

We release every batch with a lot-specific certificate of analysis, which means we field the same question from lab buyers constantly: why does the IGF-1 LR3 price sit so far above a short synthetic peptide of the same milligram weight? The answer is production chemistry. Not margin, not branding.

How much does IGF-1 LR3 cost?

IGF-1 LR3 price typically runs from roughly $40 to over $100 for a 1mg research vial, with cost per milligram falling as fill size increases. That spread reflects expression method, refolding yield, purity verification depth and net peptide content. Compare cost per milligram of verified net protein, never cost per vial.

The common over-simplification is that IGF-1 LR3 price scales neatly with vial size. It doesn't, because the expensive part of making this molecule happens after the sequence exists. Recombinant expression, oxidative refolding and chromatographic purification each consume yield, and yield is what a buyer is really paying for. This page covers what sets the IGF-1 LR3 price at the production bench, how to read a certificate of analysis before comparing any two listings, and where a low sticker number quietly costs more than it saves.

Why an 83-residue protein doesn't price like a short peptide

IGF-1 LR3 costs more per milligram than most catalog peptides because it cannot be manufactured the same way. Native human IGF-1 is a 70-amino-acid single-chain protein of roughly 7,650 Da. The LR3 analog substitutes arginine for glutamic acid at position 3 and adds a 13-residue N-terminal extension, producing an 83-residue molecule of roughly 9,100 Da. Both modifications reduce affinity for the IGF binding proteins (IGFBPs), the carrier proteins that normally sequester IGF-1 in serum and in culture media, which is why the analog became a standard supplement in recombinant protein cell culture.

Solid-phase peptide synthesis (SPPS) builds a chain one residue at a time on a resin support and works cleanly up to roughly 40 to 50 residues. Every coupling step falls slightly short of quantitative, and those small inefficiencies compound. Across 80-plus steps, the fraction of full-length chains in the crude mixture collapses. So IGF-1 LR3 is produced by recombinant expression, commonly in E. coli, then refolded so its three disulfide bridges pair in the correct configuration before purification. Refolding yield is the single largest variable behind any finished IGF-1 LR3 price.

Hold that against a 15-residue synthetic such as BPC-157, which comes off a synthesizer with no folding step at all. Same milligram on the label, entirely different cost structure underneath it. Our team sees buyers make that comparison weekly.

What a certificate of analysis tells you before any number matters

A purity figure with no lot number attached is marketing, not data. HPLC purity of 98% or higher describes chromatographic purity: how much of the injected material eluted as a single main peak. Mass spectrometry confirms the measured molecular mass matches the expected sequence. Neither test resolves the problem that is specific to this molecule.

Disulfide isomers, meaning molecules whose three bridges have paired in the wrong combination, carry the same molecular mass as correctly folded protein and can elute very close to it. HPLC and MS can both look clean while a share of the vial is misfolded and inactive. Cell-based bioactivity data, where a supplier publishes it, is the only routine assay that separates the two. That is the detail most listing pages never mention, and it is where the real difference between two effective IGF-1 LR3 price points usually hides.

The second line worth reading is net peptide content. A lyophilized vial holds counterions from purification (acetate or trifluoroacetate), residual moisture and any bulking excipient such as mannitol. Gross fill weight includes all of it. Anyone comparing an IGF-1 LR3 price should request the certificate of analysis for the specific lot they would receive, not a representative document from an older batch.

Where a low sticker number gets expensive

Cold chain and solvent chemistry destroy more research protein than poor synthesis does. Lyophilized IGF-1 LR3 is held frozen for long-term storage, commonly at -20°C or colder, with reconstituted solution kept refrigerated at 2 to 8°C and handled to avoid repeated freeze-thaw cycles. A supplier shipping uninsulated in summer transit is transferring a real cost onto the buyer, and protein denaturation leaves no visible signature in the vial.

Solvent choice compounds it. This analog has poor solubility near neutral pH, and published laboratory handling uses a dilute acid such as 10 mM hydrochloric acid or dilute acetic acid rather than plain water. Laboratories working at low concentrations also add a carrier protein to limit adsorption losses, because dilute protein readily sticks to glass and plastic surfaces. Material dissolved in the wrong solvent can lose activity before a single measurement is recorded, and that loss never appears in an IGF-1 LR3 price comparison.

One point of framing that is not negotiable: everything in our catalog is research-use-only material. It is not a drug product, it is not FDA-approved, and it is not intended for human or animal administration. Anyone with a question about an animal's health should talk to their veterinarian, not a peptide catalog.

IGF-1 LR3 price by vial size: what you're actually comparing

Per-milligram cost drops as fill size rises, but the trade-off is stability, since a larger vial becomes one solution with a finite usable life once reconstituted. The table shows how listed IGF-1 LR3 price behaves across common research formats and what genuinely changes at each tier.

Vial format	Typical listed range	Relative cost per mg	What changes at this tier	Bottom line
0.1mg assay vial	Lowest absolute outlay of any format	Highest per mg, often several times the 1mg rate	Handling and adsorption losses are proportionally largest at this scale	Reasonable for a single pilot run, poor economics for anything continuous
1mg vial	Roughly $40 to over $100 across research suppliers	The reference unit most buyers anchor to	Most widely stocked format, so COAs are easiest to compare vendor to vendor	The correct unit for benchmarking any supplier against another
5mg vial	Usually a multiple of the 1mg vial rather than a straight 5x	Meaningfully lower per mg	One reconstitution event covers a longer experimental series, so solution stability becomes the limiting factor	Best balance when the protocol is defined and continuous
10mg or bulk fill	Highest absolute outlay, lowest unit cost	Lowest per mg by a clear margin	Requires reliable freezer capacity and disciplined aliquoting	Only economical if the lab can consume it before degradation sets in
Unbranded bulk, no COA	Frequently far below every tier above	Unknowable, because net content is unverified	No lot traceability, no purity method disclosed, no recourse on a bad batch	Not a price comparison at all, it is a different product category

What If: sourcing and storage scenarios

What if two suppliers list the same vial size at wildly different numbers?

Request the lot-specific certificate from both before comparing anything else. A two-fold or three-fold gap on an identical fill size almost always traces back to one of three variables: net peptide content versus gross weight, the depth of purity verification performed, or whether the vendor pays for cold-chain shipping. If one supplier publishes HPLC, mass spec and bioactivity data and the other publishes a percentage with no method listed, you are not comparing equivalent material.

What if the vial arrives warm or with no cold packs?

Photograph the packaging and contact the supplier before opening anything. Lyophilized protein tolerates short ambient excursions considerably better than protein in solution, which is why powder ships more forgivingly than premixed formats. Prolonged or repeated warmth can still denature the molecule with no visible change to the cake, so appearance is not a usable check. Document the arrival condition immediately, since traceability claims weaken fast once a lot has been opened.

What if the powder looks like almost nothing in the vial?

Check the certificate rather than the glass. A 1mg lyophilized fill frequently appears as a thin film or a barely visible deposit at the vial base, and that is completely normal for protein at this scale. Some suppliers add a bulking excipient such as mannitol, which makes an identical mass look substantially larger. Visual volume tells you about the excipient, not the protein. Documented net content is the only number that answers the question.

What if a supplier will not provide a lot-specific certificate?

Treat that refusal as disqualifying and move on. In our experience, a vendor declining to produce lot-level documentation either did not commission independent testing for that batch or is circulating a certificate that belongs to a different lot entirely. Lot traceability is the only mechanism linking what you paid to what arrived in the box. Without it, purity, net content and storage history are all assertions rather than data.

The unglamorous truth about cheap IGF-1 LR3 vials

Here's the honest answer: below a certain point, a low IGF-1 LR3 price is not a discount, it is a different product. Recombinant expression, oxidative refolding and multi-step purification have a hard floor in cost, and nothing about scale removes it. When a listing sits far under that floor, something was skipped. Usually it is the refolding fraction, the bioactivity assay, the cold-chain shipping, or all three. The vial still looks identical. The data behind it does not exist.

Our full catalog, lot certificates and current research vial listings are available on the IGF-1 LR3 product page, alongside the broader peptide shop and our published certificates of analysis. Buyers wanting the technical background rather than the purchasing view can work through our IGF-1 LR3 questions answered reference, and shipping and sourcing details sit on our location page.

IGF-1 LR3 price is one of the few numbers in a research budget that actively misleads, because it is quoted against gross weight while the experiment runs on correctly folded net protein. The gap between those two figures is invisible on a product page and obvious on a certificate of analysis. Read the certificate first and the number second, and the expensive vial frequently turns out to be the cheaper one per usable milligram.

References

Peer-reviewed sources on IGF-1 LR3 indexed in PubMed, listed for research context. Real Peptides supplies IGF-1 LR3 for laboratory research use only.

IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep. American journal of physiology. Endocrinology and metabolism, 2025. PMID 39679943. doi:10.1152/ajpendo.00259.2024
Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice. Journal of Alzheimer's disease : JAD, 2025. PMID 39610283. doi:10.1177/13872877241299056
Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris. Applied microbiology and biotechnology, 2023. PMID 37261455. doi:10.1007/s00253-023-12606-0
Attenuated glucose-stimulated insulin secretion during an acute IGF-1 LR3 infusion into fetal sheep does not persist in isolated islets. Journal of developmental origins of health and disease, 2023. PMID 37114757. doi:10.1017/S2040174423000090
Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig. The Journal of endocrinology, 1995. PMID 7561636. doi:10.1677/joe.0.1460247

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

IGF-1 LR3 price typically runs from roughly $40 to over $100 for a 1mg research vial across suppliers, with larger 5mg and 10mg fills lowering the cost per milligram. The range reflects production method, purity verification and net peptide content rather than branding. Always convert a listed vial price into cost per milligram of verified net protein before comparing vendors.

IGF-1 LR3 is an 83-amino-acid recombinant protein, far too long for practical solid-phase peptide synthesis, which loses full-length product across 80-plus coupling steps. It is instead expressed in a host organism and then refolded so three disulfide bridges pair correctly before purification. That refolding step limits yield, and low yield is the main reason an IGF-1 LR3 price sits above a 15-residue synthetic peptide of equal weight.

Request the lot-specific certificate of analysis from each supplier and locate net peptide content, not gross fill weight. Divide the listed price by net milligrams to get a genuine unit cost, then check which purity methods were run. A vendor reporting HPLC, mass spectrometry and bioactivity data is selling verifiable material; a vendor reporting a bare percentage is selling an assertion.

Not always, but below a certain floor it usually means something in the process was skipped. Recombinant expression, oxidative refolding and chromatographic purification carry fixed costs that scale cannot eliminate. When a listing sits far under the market floor, the shortfall is commonly in refolding fraction, independent testing, or cold-chain shipping, and none of those omissions are visible in the vial.

IGF-1 LR3 is supplied as research-use-only material for laboratory and research applications. It is not an approved drug product and is not intended for human or animal administration, so it is not sold as a treatment for any condition. Anyone with a question about an animal's health should speak with their veterinarian rather than a peptide supplier.

At minimum it should carry a specific lot number, the HPLC purity result with the method stated, a mass spectrometry result confirming the expected molecular mass of roughly 9,100 Da, and the net peptide content. Bioactivity data adds real value for this molecule because disulfide isomers share an identical mass and cannot be distinguished by MS alone. A certificate with no lot number attached is not usable documentation.

Lyophilized material is held frozen for long-term storage, commonly at -20°C or colder, with reconstituted solution kept refrigerated between 2 and 8°C. Repeated freeze-thaw cycles degrade protein structure, so laboratories typically aliquot a reconstituted vial rather than thawing the whole volume repeatedly. Temperature damage does not change the appearance of the powder or the solution, which is why arrival condition should be documented on delivery.

Yes, per-milligram cost drops as fill size increases, but the saving is only real if the lab can consume the material before it degrades. A 10mg vial becomes one solution with a finite usable life once reconstituted, so the practical constraint shifts from price to freezer capacity and aliquoting discipline. For a short pilot study, a 1mg vial is frequently the better economics despite the higher unit rate.

Net peptide content is the mass of actual protein in the vial, excluding counterions such as acetate or trifluoroacetate left from purification, residual moisture, and any bulking excipient like mannitol. Gross fill weight includes all of those components. Since suppliers commonly price against gross weight, the effective cost per milligram of protein is higher than the label implies unless net content is stated.

This analog has poor solubility near neutral pH, and published laboratory handling uses a dilute acid such as 10 mM hydrochloric acid or dilute acetic acid rather than plain water. Laboratories working at low concentrations also add a carrier protein to reduce adsorption losses to glass and plastic surfaces. Solvent choice is a documented handling variable, and using the wrong one can leave undissolved material behind.

No. IGF-1 LR3 is not an FDA-approved drug product and is supplied strictly as research-use-only material for laboratory work. It is widely used as a cell-culture supplement in recombinant protein production because its modified structure shows reduced affinity for IGF binding proteins. Any claim that it is approved, or that it treats or cures a condition, is inaccurate.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA